Literature DB >> 18281649

Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.

Anthony V D'Amico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18281649     DOI： 10.1200/JCO.2007.15.1902

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

2.  A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.

Authors:  James R Hébert; Thomas G Hurley; Brook E Harmon; Sue Heiney; Christine J Hebert; Susan E Steck
Journal:  Cancer Epidemiol       Date:  2011-10-20       Impact factor: 2.984

Review 3.  [PSA--Quo vadis?].

Authors:  C Börgermann; H Loertzer; H-J Luboldt; P Hammerer; P Fornara; M Graefen; H Rübben
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

4.  Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.

Authors:  Julio Guilherme Balieiro Bernardes; Marianne Rodrigues Fernandes; Juliana Carla Gomes Rodrigues; Lui Wallacy Morikawa Souza Vinagre; Lucas Favacho Pastana; Elizabeth Ayres Fragoso Dobbin; Jéssyca Amanda Gomes Medeiros; Leonidas Braga Dias Junior; Gabriel Monteiro Bernardes; Izabel Maria Monteiro Bernardes; Ney Pereira Carneiro Dos Santos; Samia Demachki; Rommel Mario Rodriguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-30       Impact factor: 4.141
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.